Fairmount Funds Management LLC
CIK: 0001802528
Director10% Owner
Primary company: Cogent Biosciences, Inc. (COGT)
Fairmount Funds Management LLC is a corporate insider at Cogent Biosciences, Inc. (COGT) filing SEC Form 4 transactions. 20 transactions, totaling $64,499,753 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Conversion | 7,000,000 | - | - | 39,414 | 3/31/2026 Filed: 3/31/2026 | Filing → | |
| Sale | 7,000,000 | $34.66 | $242.62M | 5,503,418 | 3/31/2026 Filed: 3/31/2026 | Filing → | |
| Conversion | 7,000,000 | - | - | 12,503,418 | 3/31/2026 Filed: 3/31/2026 | Filing → | |
| Purchase | 2,777,777 | $9.00 | $25.00M | 9,003,418 | 7/10/2025 Filed: 7/14/2025 | Filing → | |
| Exercise | 1,500 | - | - | 0 | 6/10/2024 Filed: 6/12/2024 | Filing → | |
| Exercise | 1,500,000 | - | - | 6,225,641 | 6/10/2024 Filed: 6/12/2024 | Filing → | |
| J | 11,914 | - | - | 67,414 | 3/28/2024 Filed: 4/1/2024 | Filing → | |
| J | 11,914 | - | - | 0 | 3/28/2024 Filed: 4/1/2024 | Filing → | |
| J | 286,851 | - | - | 4,725,641 | 3/28/2024 Filed: 4/1/2024 | Filing → | |
| J | 286,851 | - | - | 0 | 3/28/2024 Filed: 4/1/2024 | Filing → | |
| Award | 1,500 | $7500.00 | $11.25M | 1,500 | 2/16/2024 Filed: 2/16/2024 | Filing → | |
| Award | 1,166,666 | $7.50 | $8.75M | 4,438,790 | 2/16/2024 Filed: 2/16/2024 | Filing → | |
| Purchase | 800,000 | $12.00 | $9.60M | 3,272,124 | 6/9/2023 Filed: 6/13/2023 | Filing → | |
| Purchase | 1,200,000 | $8.25 | $9.90M | 2,472,124 | 6/16/2022 Filed: 6/21/2022 | Filing → | |
Unum Therapeutics Inc. UMRX | Purchase | 19,035 | $880.00 | $16.75M | 55,500 | 7/9/2020 Filed: 7/13/2020 | Filing → |
Unum Therapeutics Inc. UMRX | Purchase | 3,692 | $880.00 | $3.25M | 11,914 | 7/9/2020 Filed: 7/13/2020 | Filing → |
Unum Therapeutics Inc. UMRX | J | 36,465 | - | - | 36,465 | 7/6/2020 Filed: 7/8/2020 | Filing → |
Unum Therapeutics Inc. UMRX | J | 8,222 | - | - | 8,222 | 7/6/2020 Filed: 7/8/2020 | Filing → |
Unum Therapeutics Inc. UMRX | J | 5,088,497 | $0.00 | $0 | 5,088,497 | 7/6/2020 Filed: 7/8/2020 | Filing → |
Unum Therapeutics Inc. UMRX | J | 1,147,406 | $0.00 | $0 | 1,147,406 | 7/6/2020 Filed: 7/8/2020 | Filing → |
Type
Conversion
Shares
7,000,000
Price
-
Value
-
Type
Sale
Shares
7,000,000
Price
$34.66
Value
$242.62M
Type
Conversion
Shares
7,000,000
Price
-
Value
-
Type
Purchase
Shares
2,777,777
Price
$9.00
Value
$25.00M
Type
Exercise
Shares
1,500
Price
-
Value
-
Type
Exercise
Shares
1,500,000
Price
-
Value
-
Type
J
Shares
11,914
Price
-
Value
-
Type
J
Shares
11,914
Price
-
Value
-
Type
J
Shares
286,851
Price
-
Value
-
Type
J
Shares
286,851
Price
-
Value
-
Type
Award
Shares
1,500
Price
$7500.00
Value
$11.25M
Type
Award
Shares
1,166,666
Price
$7.50
Value
$8.75M
Type
Purchase
Shares
800,000
Price
$12.00
Value
$9.60M
Type
Purchase
Shares
1,200,000
Price
$8.25
Value
$9.90M
Unum Therapeutics Inc.
UMRX
Type
Purchase
Shares
19,035
Price
$880.00
Value
$16.75M
Unum Therapeutics Inc.
UMRX
Type
Purchase
Shares
3,692
Price
$880.00
Value
$3.25M
Unum Therapeutics Inc.
UMRX
Type
J
Shares
36,465
Price
-
Value
-
Unum Therapeutics Inc.
UMRX
Type
J
Shares
8,222
Price
-
Value
-
Unum Therapeutics Inc.
UMRX
Type
J
Shares
5,088,497
Price
$0.00
Value
$0
Unum Therapeutics Inc.
UMRX
Type
J
Shares
1,147,406
Price
$0.00
Value
$0
AI Agent
Try asking...